Llwytho...
Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
Purpose: Serous adenocarcinoma is a rare, aggressive histologic subtype of endometrial cancer with a high rate of recurrence and a poor prognosis. The optimal adjuvant treatment for early-stage patients is unclear. Our objective was to evaluate the outcomes of stage IA serous endometrial cancers onl...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cureus |
|---|---|
| Prif Awduron: | , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Cureus
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267614/ https://ncbi.nlm.nih.gov/pubmed/30524915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3387 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|